| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Chronic diseases in elderly men: underreporting and underdiagnosis.
|
Age Ageing
|
2011
|
1.48
|
|
2
|
The relationship between health-related quality of life, obesity and testosterone levels in older men.
|
Age Ageing
|
2013
|
1.47
|
|
3
|
Is glycyrrhizin sensitivity increased in anorexia nervosa and should licorice be avoided? Case report and review of the literature.
|
Nutrition
|
2010
|
1.45
|
|
4
|
Suppression of endogenous testosterone production attenuates the response to strength training: a randomized, placebo-controlled, and blinded intervention study.
|
Am J Physiol Endocrinol Metab
|
2006
|
1.24
|
|
5
|
Visceral and subcutaneous adipose tissue assessed by magnetic resonance imaging in relation to circulating androgens, sex hormone-binding globulin, and luteinizing hormone in young men.
|
J Clin Endocrinol Metab
|
2007
|
1.21
|
|
6
|
Association of pioglitazone treatment with decreased bone mineral density in obese premenopausal patients with polycystic ovary syndrome: a randomized, placebo-controlled trial.
|
J Clin Endocrinol Metab
|
2008
|
1.20
|
|
7
|
Factors influencing the adrenocorticotropin test: role of contemporary cortisol assays, body composition, and oral contraceptive agents.
|
J Clin Endocrinol Metab
|
2007
|
1.04
|
|
8
|
An update on the pathogenesis, inflammation, and metabolism in hirsutism and polycystic ovary syndrome.
|
Gynecol Endocrinol
|
2010
|
1.02
|
|
9
|
Incidence of GH deficiency - a nationwide study.
|
Eur J Endocrinol
|
2006
|
1.01
|
|
10
|
Soluble CD36 and risk markers of insulin resistance and atherosclerosis are elevated in polycystic ovary syndrome and significantly reduced during pioglitazone treatment.
|
Diabetes Care
|
2007
|
0.98
|
|
11
|
Association of polycystic ovary syndrome susceptibility single nucleotide polymorphism rs2479106 and PCOS in Caucasian patients with PCOS or hirsutism as referral diagnosis.
|
Eur J Obstet Gynecol Reprod Biol
|
2012
|
0.97
|
|
12
|
Total and high molecular weight (HMW) adiponectin levels and measures of glucose and lipid metabolism following pioglitazone treatment in a randomized placebo-controlled study in polycystic ovary syndrome.
|
Clin Endocrinol (Oxf)
|
2007
|
0.93
|
|
13
|
Long-term outcome and MGMT as a predictive marker in 24 patients with atypical pituitary adenomas and pituitary carcinomas given treatment with temozolomide.
|
J Clin Endocrinol Metab
|
2015
|
0.93
|
|
14
|
Testosterone therapy increased muscle mass and lipid oxidation in aging men.
|
Age (Dordr)
|
2011
|
0.93
|
|
15
|
Plasma monocyte chemoattractant protein-1 (MCP-1) and macrophage inflammatory protein-1alpha are increased in patients with polycystic ovary syndrome (PCOS) and associated with adiposity, but unaffected by pioglitazone treatment.
|
Clin Endocrinol (Oxf)
|
2009
|
0.92
|
|
16
|
Prevalence of endocrine diseases and abnormal glucose tolerance tests in 340 Caucasian premenopausal women with hirsutism as the referral diagnosis.
|
Fertil Steril
|
2004
|
0.91
|
|
17
|
Geographical variation in DXA bone mineral density in young European men and women. Results from the Network in Europe on Male Osteoporosis (NEMO) study.
|
Bone
|
2008
|
0.91
|
|
18
|
Evaluation of metabolic risk markers in polycystic ovary syndrome (PCOS). Adiponectin, ghrelin, leptin and body composition in hirsute PCOS patients and controls.
|
Eur J Endocrinol
|
2006
|
0.91
|
|
19
|
MTHFR c.677C>T polymorphism as an independent predictor of peak bone mass in Danish men--results from the Odense Androgen Study.
|
Bone
|
2005
|
0.90
|
|
20
|
Mortality and GH deficiency: a nationwide study.
|
Eur J Endocrinol
|
2007
|
0.89
|
|
21
|
Effect of pioglitazone on glucose metabolism and luteinizing hormone secretion in women with polycystic ovary syndrome.
|
Fertil Steril
|
2006
|
0.86
|
|
22
|
Prevalence of posttraumatic growth hormone deficiency is highly dependent on the diagnostic set-up: results from The Danish National Study on Posttraumatic Hypopituitarism.
|
J Clin Endocrinol Metab
|
2013
|
0.86
|
|
23
|
A common LRP4 haplotype is associated with bone mineral density and hip geometry in men-data from the Odense Androgen Study (OAS).
|
Bone
|
2013
|
0.85
|
|
24
|
Osteoporosis and vertebral fractures in men aged 60-74 years.
|
Age Ageing
|
2012
|
0.85
|
|
25
|
Ethnic differences in Rotterdam criteria and metabolic risk factors in a multiethnic group of women with PCOS studied in Denmark.
|
Clin Endocrinol (Oxf)
|
2010
|
0.85
|
|
26
|
The impact of pegvisomant treatment on substrate metabolism and insulin sensitivity in patients with acromegaly.
|
J Clin Endocrinol Metab
|
2007
|
0.85
|
|
27
|
Suppression of testosterone does not blunt mRNA expression of myoD, myogenin, IGF, myostatin or androgen receptor post strength training in humans.
|
J Physiol
|
2006
|
0.85
|
|
28
|
Clinical manifest x-linked recessive adrenoleukodystrophy in a female.
|
Case Rep Neurol Med
|
2013
|
0.85
|
|
29
|
Pegylated long-acting human growth hormone possesses a promising once-weekly treatment profile, and multiple dosing is well tolerated in adult patients with growth hormone deficiency.
|
J Clin Endocrinol Metab
|
2010
|
0.85
|
|
30
|
Smoking is associated with increased adrenal responsiveness, decreased prolactin levels and a more adverse lipid profile in 650 white patients with polycystic ovary syndrome.
|
Gynecol Endocrinol
|
2011
|
0.84
|
|
31
|
Association study of polymorphisms in the SOST gene region and parameters of bone strength and body composition in both young and elderly men: data from the Odense Androgen Study.
|
Calcif Tissue Int
|
2011
|
0.84
|
|
32
|
Body composition is improved during 12 months' treatment with metformin alone or combined with oral contraceptives compared with treatment with oral contraceptives in polycystic ovary syndrome.
|
J Clin Endocrinol Metab
|
2014
|
0.84
|
|
33
|
A 12-month randomized crossover study on the effects of lanreotide Autogel and octreotide long-acting repeatable on GH and IGF-l in patients with acromegaly.
|
Clin Endocrinol (Oxf)
|
2007
|
0.83
|
|
34
|
Fracture risk is increased in patients with GH deficiency or untreated prolactinomas--a case-control study.
|
Clin Endocrinol (Oxf)
|
2002
|
0.82
|
|
35
|
Hemoglobin A1c as a tool for the diagnosis of type 2 diabetes in 208 premenopausal women with polycystic ovary syndrome.
|
Fertil Steril
|
2011
|
0.82
|
|
36
|
Giant prolactinomas in women.
|
Eur J Endocrinol
|
2013
|
0.82
|
|
37
|
Higher bone mineral density in Caucasian, hirsute patients of reproductive age. Positive correlation of testosterone levels with bone mineral density in hirsutism.
|
Clin Endocrinol (Oxf)
|
2005
|
0.81
|
|
38
|
Morbidity and GH deficiency: a nationwide study.
|
Eur J Endocrinol
|
2008
|
0.81
|
|
39
|
Mechanical muscle function and lean body mass during supervised strength training and testosterone therapy in aging men with low-normal testosterone levels.
|
J Am Geriatr Soc
|
2013
|
0.80
|
|
40
|
Common genetic variation in the DKK1 gene is associated with hip axis length but not with bone mineral density and bone turnover markers in young adult men: results from the Odense Androgen Study.
|
Calcif Tissue Int
|
2010
|
0.80
|
|
41
|
The impact of the CAG repeat polymorphism of the androgen receptor gene on muscle and adipose tissues in 20-29-year-old Danish men: Odense Androgen Study.
|
Eur J Endocrinol
|
2010
|
0.80
|
|
42
|
Dehydroepiandrosterone substitution in female adrenal failure: no impact on endothelial function and cardiovascular parameters despite normalization of androgen status.
|
Clin Endocrinol (Oxf)
|
2007
|
0.79
|
|
43
|
Birth weight and polycystic ovary syndrome in adult life: a register-based study on 523,757 Danish women born 1973-1991.
|
Fertil Steril
|
2012
|
0.79
|
|
44
|
Thiazolinedione treatment in PCOS--an update.
|
Gynecol Endocrinol
|
2010
|
0.78
|
|
45
|
Graphical interpretation of confidence curves in rankit plots.
|
Clin Chem Lab Med
|
2004
|
0.78
|
|
46
|
Pioglitazone treatment increases spontaneous growth hormone (GH) secretion and stimulated GH levels in polycystic ovary syndrome.
|
J Clin Endocrinol Metab
|
2005
|
0.78
|
|
47
|
Evaluation of growth hormone stimulation tests in cured acromegalic patients.
|
Growth Horm IGF Res
|
2003
|
0.78
|
|
48
|
Very short term dehydroepiandrosterone treatment in female adrenal failure: impact on carbohydrate, lipid and protein metabolism.
|
Eur J Endocrinol
|
2005
|
0.78
|
|
49
|
Hyperandrogenism and phenotypes of polycystic ovary syndrome are not associated with differences in obstetric outcomes.
|
Acta Obstet Gynecol Scand
|
2014
|
0.78
|
|
50
|
Slow-growing craniopharyngioma masquarading as early-onset eating disorder: two cases.
|
Int J Eat Disord
|
2009
|
0.78
|
|
51
|
Dehydroepiandrosterone supplementation in women with adrenal failure: impact on twenty-four hour GH secretion and IGF-related parameters.
|
Clin Endocrinol (Oxf)
|
2004
|
0.77
|
|
52
|
Discontinuation of estrogen replacement therapy in GH-treated hypopituitary women alters androgen status and IGF-I.
|
Eur J Endocrinol
|
2005
|
0.77
|
|
53
|
Heart valve disease among patients with hyperprolactinemia: a nationwide population-based cohort study.
|
J Clin Endocrinol Metab
|
2012
|
0.77
|
|
54
|
Resistin polymorphisms show associations with obesity, but not with bone parameters in men: results from the Odense Androgen Study.
|
Mol Biol Rep
|
2012
|
0.76
|
|
55
|
Genetic association study of WNT10B polymorphisms with BMD and adiposity parameters in Danish and Belgian males.
|
Endocrine
|
2013
|
0.76
|
|
56
|
Association study of common variants in the sFRP1 gene region and parameters of bone strength and body composition in two independent healthy Caucasian male cohorts.
|
Mol Genet Metab
|
2011
|
0.76
|
|
57
|
Single nucleotide polymorphisms in sFRP4 are associated with bone and body composition related parameters in Danish but not in Belgian men.
|
Mol Genet Metab
|
2012
|
0.75
|
|
58
|
[Complications in pregnant women with polycystic ovary syndrome].
|
Ugeskr Laeger
|
2016
|
0.75
|
|
59
|
Risk of impaired glucose tolerance in normal weight hirsute women during four years observation.
|
Acta Obstet Gynecol Scand
|
2010
|
0.75
|
|
60
|
[Acromegaly: new principles for treatment].
|
Ugeskr Laeger
|
2007
|
0.75
|
|
61
|
[Changes in reporting on passive smoking by parents of small children].
|
Tidsskr Nor Laegeforen
|
2004
|
0.75
|
|
62
|
Adiponectin, interleukin-6, monocyte chemoattractant protein-1, and regional fat mass during 12-month randomized treatment with metformin and/or oral contraceptives in polycystic ovary syndrome.
|
J Endocrinol Invest
|
2014
|
0.75
|
|
63
|
[The Odense Androgen Study].
|
Ugeskr Laeger
|
2004
|
0.75
|
|
64
|
[Endocrinological assessment, treatment and follow-up on polycystic ovary syndrome].
|
Ugeskr Laeger
|
2010
|
0.75
|
|
65
|
Medical comorbidity in polycystic ovary syndrome with special focus on cardiometabolic, autoimmune, hepatic and cancer diseases: an updated review.
|
Curr Opin Obstet Gynecol
|
2017
|
0.75
|
|
66
|
Diagnosis of growth hormone deficiency.
|
Front Horm Res
|
2005
|
0.75
|
|
67
|
A randomized placebo-controlled study on the effects of pioglitazone on cortisol metabolism in polycystic ovary syndrome.
|
Fertil Steril
|
2008
|
0.75
|
|
68
|
[Dopamin agonist treatment and fibrotic heart valve disease in hyperprolactinaemia patients].
|
Ugeskr Laeger
|
2014
|
0.75
|